Клинические рекомендации Европейского респираторного общества по оценке кашля

1. Office of Population Censuses and Surveys, Morbidity Statistics from General Practice: 4th National Study 1991-1992. Series MB5 no. 3. London: Her Majesty's Stationery Office; 1995.

2. Schappert S.M. Ambulatory care visits of physician offices, hospital outpatient departments, and emergency departments: United States, 1995. Vital Hlth Stat. 1997; 13 (129): 1-38.

3. Fendrick A.M., Monto A.S., Nightengale B., Sarnes M. The economic burden of non-influenza-related viral respiratory tract infection in the United States. Arch. Intern. Med. 2003; 163: 487-494.

4. Irwin R.S., Curley F.J., French C.L. Chronic cough. The spectrum and frequency of causes, key components of the diagnostic evaluation, and outcome of specific therapy. Am. Rev. Respir. Dis. 1990; 141: 640-647.

5. McGarvey L.P.A., Heaney L.G., MacMahon J. A retrospective survey of diagnosis and management of patients presenting with chronic cough to a general chest clinic. Int. J. Clin. Pract. 1998; 52: 158-161.

6. Morice A.H., Fontana G.A., Sovijarvi A.R.A. et al. The diagnosis and management of chronic cough. Eur. Respir. J. 2004; 24: 481-492.

7. Irwin R.S., Baumann M.H., Bolser D.C. et al. Diagnosis and management of cough executive summary. ACCP evidence-based clinical practice guidelines. Chest 2006; 129 (suppl. 1): 1S-23S.

8. French C.T., Irwin R.S., Fletcher K.E., Adams T.M. Evaluation of cough-specific quality of life questionnaire. Chest 2002; 121: 1123-1131.

9. Birring S.S., Prudon B., Carr A.J. et al. Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ). Thorax 2003; 58: 339-343. Online version: http://thorax.bmjjournals.com/cgi/content/full/58/4/339. Date updated: April 2003. Date accessed: January 2007.

10. Laude E.A., Higgins K.S., Morice A.H. A comparative study of the effects of citric acid, capsaicin and resiniferatoxin on the cough challenge in guinea-pig and man. Pulm. Pharmacol. 1993; 6: 171-175.

11. Dicpinigaitis P.V. Short- and long-term reproducibility of capsaicin cough challenge testing. Pulm. Pharmacol. Ther. 2003; 16: 61-65.

12. Widdicombe J., Fontana G. Cough: what's in a name? Eur. Respir. J. 2006; 28: 10-15.

13. Korpas J., Tomori Z. Cough and other respiratory reflexes. Basle: S. Karger; 1979.

14. Morice A.H., McGarvey L., Pavord I. Recommendations for the management of cough in adults. Thorax 2006; 61 (suppl. 1): i1-i24.

15. Collier J.G., Fuller RW. Capsaicin inhalation in man and the effects of sodium cromoglycate. Br. J. Pharmacol. 1984; 81: 113-117.

16. Bickerman H.A., Barach A.L., Itkin S., Drimmer F. Experimental production of cough in human subjects induced by citric acid aerosols. Preliminary studies on the evaluation of antitussive agents. Am. J. Med. Sci. 1954; 228: 156-163.

17. Bickerman H.A., German E., Cohen B.M. The cough response of healthy human subjects stimulated by citric acid aerosol. Am. J. Med. Sci. 1957; 234: 191-205.

18. Midgren B., Hansson L., Karlsson J.A. et al. Capsaicin-induced cough in humans. Am. Rev. Respir. Dis. 1992; 146: 347-351.

19. Fujimura M., Kamio Y., Hashimoto T., Matsuda T. Cough receptor sensitivity and bronchial responsiveness in patients with only chronic nonproductive cough: in view of effect of bronchodilator therapy. J. Asthma 1994; 31: 463-472.

20. Dicpinigaitis P.V., Dobkin J.B. Antitussive effect of the GABA-agonist baclofen. Chest 1997; 111: 996-999.

21. Kopec S.E., DeBellis R.J., Irwin R.S. Chemical analysis of freshly prepared and stored capsaicin solutions: implications for tussigenic challenges. Pulm. Pharmacol. Ther 2002; 15: 529-534.

22. Kastelik J.A., Thompson R.H., Aziz I. et al. Sex-related differences in cough reflex sensitivity in patients with chronic cough. Am. J. Respir. Crit. Care Med. 2002; 166: 961-964.

23. Wong C.H., Matai R., Morice A.H. Cough induced by low pH. Respir. Med. 1999; 93: 58-61.

24. Wong C.H., Morice A.H. Cough threshold in patients with chronic obstructive pulmonary disease. Thorax 1999; 54: 62-64.

25. Morice A.H., Kastelik J.A., Thompson R. Cough challenge in the assessment of cough reflex. Br. J. Clin. Pharmacol. 2001; 52: 365-375.

26. Nejla S., Fujimura M., Kamio Y. Comparison between tidal breathing and dosimeter methods in assessing cough receptor sensitivity to capsaicin. Respirology 2000; 5: 337-342.

27. Barros M.J., Zammattio S.L., Rees P.J. Effect of changes in inspiratory flow rate on cough responses to inhaled capsaicin. Clin. Sci. (Lond) 1991; 81: 539-542.

28. Barros M.J., Zammattio S.J., Rees P.J. Importance of inspiratory flow rate in the cough response to citric acid inhalation in normal subjects. Clin. Sci. (Lond) 1990; 78: 521-525.

29. O'Connell F., Thomas V.E., Studham J.M. et al. Capsaicin cough sensitivity increases during upper respiratory infection. Respir. Med. 1996; 90: 279-286.

30. Hansson L., Wollmer P., Dahlback M., Karlsson J.A. Regional sensitivity of human airways to capsaicininduced cough. Am. Rev. Respir. Dis. 1992; 145: 1191-1195.

31. Hutchings H.A., Morris S., Eccles R., Jawad M.S. Voluntary suppression of cough induced by inhalation of capsaicin in healthy volunteers. Respir. Med. 1993; 87: 379-382.

32. Prudon B, Vara D.D., Pavord I.D., Birring S.S. Analysis of cough reflex sensitivity data. Thorax 2005; 60 (suppl. II): ii107.

33. Prudon B., Birring S.S., Vara D.D. et al. Cough and glottic-stop reflex sensitivity in health and disease. Chest 2005; 127: 550-557.

34. Crapo R.O., Casaburi R., Coates A.L. et al. Guidelines for methacholine and exercise challenge testing - 1999. Am. J. Respir. Crit. Care Med. 2000; 161: 309-329.

35. Morice A.H., Higgins K.S., Yeo W.W. Adaptation of cough reflex with different types of stimulation. Eur. Respir. J. 1992; 5: 841-847.

36. Schmidt D., Jorres R.A., Magnussen H. Citric acid-induced cough thresholds in normal subjects, patients with bronchial asthma, and smokers. Eur. J. Med. Res. 1997; 2: 384-388.

37. Barber C.M., Curran A.D., Bradshaw L.M. et al. Reproducibility and validity of a Yan-style portable citric acid cough challenge. Pulm. Pharmacol. Ther. 2005; 18: 177-180.

38. Grattan T.J., Marshall A.E., Higgins K.S., Morice A.H. The effect of inhaled and oral dextromethorphan on citric acid induced cough in man. Br. J. Clin. Pharmacol. 1995; 39: 261-263.

39. Morice A.H., Marshall A.E., Higgins K.S., Grattan T.J. Effect of inhaled menthol on citric acid induced cough in normal subjects. Thorax 1994; 49: 1024-1026.

40. Rostami-Hodjegan A., Abdul-Manap R., Wright C.E. et al. The placebo response to citric acid-induced cough: pharmacodynamics and gender differences. Pulm. Pharmacol. Ther. 2001; 14: 315-319.

41. Wright C.E., Campbell R.J., Morice A.H. Citric acid inhalation cough challenge in chronic cough patients and controls using the KOKO Digidoser. Proc. Am. Thorac. Soc. 2006; 3: A372.

42. Fujimura M., Kamio Y., Sakamoto S. et al. Tachyphylaxis to capsaicin-induced cough and its reversal by indomethacin, in patients with the sinobronchial syndrome. Clin. Auton. Res. 1992; 2: 397-401.

43. Fujimura M., Sakamoto S., Kamio Y., Matsuda T. Effects of methacholine induced bronchoconstriction and procaterol induced bronchodilation on cough receptor sensitivity to inhaled capsaicin and tartaric acid. Thorax 1992; 47: 441-445.

44. Nieto L., de Diego A., Perpina M. et al. Cough reflex testing with inhaled capsaicin in the study of chronic cough. Respir. Med. 2003; 97: 393-400.

45. Wright C.E., Jackson J., Thompson R.H., Morice A.H. Validation of the citric acid cough challenge using the KOKO Digidoser system in healthy adult volunteers. Proc. Am. Thorac. Soc. 2007 (in press).

46. Dicpinigaitis P.V., Alva R.V. Safety of capsaicin cough challenge testing. Chest 2005; 128: 196-202.

47. O'Connell F., Thomas V.E., Pride N.B. Adaptation of cough reflex with different types of stimulation. Eur. Respir. J. 1992; 5: 1296-1297.

48. Dicpinigaitis P.V., Rauf K. The influence of gender on cough reflex sensitivity. Chest 1998; 113: 1319-1321.

49. Fujimura M., Kasahara K., Kamio Y. et al. Female gender as a determinant of cough threshold to inhaled capsaicin. Eur. Respir. J. 1996; 9: 1624-1626.

50. Thompson R., Wright C., Morice A.H. Female gender and enhanced citric acid induced cough response. Thorax 1999; 54 (suppl. 3): A75.

51. Fujimura M., Sakamoto S., Kamio Y., Matsuda T. Sex difference in the inhaled tartaric acid cough threshold in non-atopic healthy subjects. Thorax 1990; 45: 633-634.

52. International Society for the Study of Cough. Who are we? www.hull.ac.uk/ISSC/who_are_we.html. Date last updated: January 2007. Date last accessed: January 2007.

53. Mercer T.T. Production of therapeutic aerosols; principles and techniques. Chest 1981; 80 (suppl. 6): 813-818.

54. Sterk P.J., Plomp A., van de Vate J.F., Quanjer P.H. Physical properties of aerosols produced by several jet- and ultrasonic nebulizers. Bull. Eur. Physiopathol. Respir. 1984; 20: 65-72.

55. Eschenbacher W.L., Boushey H.A., Sheppard D. Alteration in osmolarity of inhaled aerosols cause bronchoconstriction and cough, but absence of a permeant anion causes cough alone. Am. Rev. Respir. Dis. 1984; 129: 211-215.

56. Lavorini F., Fontana G.A., Pantaleo T. et al. Fog-induced respiratory responses are attenuated by nedocromil sodium in humans. Am. J. Respir. Crit. Care Med. 2001; 163: 1117-1120.

57. Fontana G.A., Pantaleo T., Lavorini F. et al. A noninvasive electromyographic study on threshold and intensity of cough in humans. Eur. Respir. J. 1997; 10: 983-989.

58. Fontana G.A., Pantaleo T., Lavorini F. et al. Defective motor control of coughing in Parkinson's disease. Am. J. Respir. Crit. Care Med. 1998; 158: 458-464.

59. Higenbottam T., Jackson M., Woolman P. et al. The cough response to ultrasonically nebulized distilled water in heart-lung transplantation patients. Am. Rev. Respir. Dis. 1989; 140: 58-61.

60. Morice A.H., Turley A.J., Linton K. Human ACE gene polymorphism and distilled water induced cough. Thorax 1997; 52: 111-113.

61. Lowry R., Higenbottam T., Johnson T., Godden D. Inhibition of artificially induced cough in man by bronchodilators. Br. J. Clin. Pharmacol. 1987; 24: 503-510.

62. Lowry R., Wood A., Johnson T., Higenbottam T. Antitussive properties of inhaled bronchodilators on induced cough. Chest 1988; 93: 1186-1189.

63. Ventresca P.G., Nichol G.M., Barnes P.J., Chung K.F. Inhaled furosemide inhibits cough induced by low chloride content solutions but not by capsaicin. Am. Rev. Respir. Dis 1990; 142: 143-146.

64. Fontana G.A., Pantaleo T., Lavorini F. et al. Coughing in laryngectomized patients. Am. J. Respir. Crit. Care Med. 1999; 160: 1578-1584.

65. Tanaka S., Hirata K., Kurihara N. et al. Effect of loratadine, an H1 antihistamine, on induced cough in non-asthmatic patients with chronic cough. Thorax 1996; 51: 810-814.

66. Fontana G.A., Pantaleo T., Lavorini F. et al. Repeatability of cough-related variables during fog challenges at threshold and suprathreshold stimulus intensity in humans. Eur. Respir. J. 1999; 13: 1447-1450.

67. Woolf C.R., Rosenberg A. Objective assessment of cough suppressants under clinical conditions using a tape recorder system. Thorax 1964; 19: 125-130.

68. Loudon R.G., Brown L.C. Cough frequency in patients with respiratory disease. Am. Rev. Respir. Dis. 1967; 96: 1137-1143.

69. Loudon R.G., Spohn S.K. Cough frequency and infectivity in patients with pulmonary tuberculosis. Am. Rev. Respir. Dis. 1969; 99: 109-111.

70. Archer L.N.J., Simpson H. Night cough counts and diary card scores in asthma. Arch. Dis. Child. 1985; 60: 473-474.

71. Hiew Y., Smith J.A., Cheetham B.M.G. et al. Automatic cough detection using digital signal processing techniques - the Manchester Cough Algorithm. Am. J. Respir. Crit. Care Med. 2002; 165: A832.

72. Birring S.S., Matos S., Patel R.B. et al. The relationship between cough counts and quality of life in patients with chronic cough. Eur. Respir. J. 2004; 24: Suppl. 48, 47s.

73. Barry S.J., Dane A.D., Morice A.H., Walmsley A.D. The automatic recognition and counting of cough. Cough 2006; 2: 8.

74. Bennett F.M., Irwin R.S., Brown L., French C.L. Automatic recognition of coughs. Am. Rev. Respir. Dis. 1991; 143: A666.

75. Hsu J.Y., Stone R.A., Logan-Sinclair R.B. et al. Coughing frequency in patients with persistent cough: assessment using a 24 hour ambulatory recorder. Eur. Respir. J. 1994; 7: 1246-1253.

76. Chang A.B., Newman R.G., Phelan P.D., Robertson C.F. A new use for an old Holter monitor: an ambulatory cough meter. Eur. Respir. J. 1997; 10: 1637-1639.

77. Subburaj S., Hirtum A.V., Quanten S., Berckmans D. An algorithm to automatically identify cough sounds from clinical recordings. Eur. Respir. J. 2003; 22 (suppl. 45): 172s.

78. Smith J.A., Cheetham B.M.G., Earis J.E., Woodcock A.A. Cough seconds: a new measure of cough. Am. J. Respir. Crit. Care Med. 2006; 165: A832.

79. Coyle M.A., Keenan B.D., Mayleben D.W. et al. Objective assessment of cough over a 24-hr period in patients with COPD. Am. J. Respir. Crit. Care Med. 2004; 169: A606.

80. Smith J., Owen E., Earis J., Woodcock A. Effect of codeine on objective measurement of cough in chronic obstructive pulmonary disease. J. Allergy Clin. Immunol. 2006; 117: 831-835.

81. Smith J.A., Owen E.C., Jones A.M. et al. Objective measurement of cough during pulmonary exacerbations in adults with cystic fibrosis. Thorax 2006; 61: 425-429.

82. Birring S.S., Matos S., Patel R.B. et al. Cough frequency, cough sensitivity and health status in patients with chronic cough. Respir. Med. 2006; 100: 1105-1109.

83. Matos S., Birring S.S., Pavord I.D., Evans D.H. Detection of cough signals in continuous audio recordings using hidden Markov models. IEEE Trans Biomed Eng. 2006; 53: 1078-1083.

84. Korpas J., Sadlonova J., Salat D., Masarova E. The origin of cough sounds. Bull. Eur. Physiopathol. Respir. 1987; 23 (suppl. 10): 47s-50s.

85. Hamutcu R., Francis J., Karakoc F., Bush A. Objective monitoring of cough in children with cystic fibrosis. Pediatr. Pulmonol. 2002; 34: 331-335.

86. Thorpe C.W., Toop L.J., Dawson K.P. Towards a quantitative description of asthmatic cough sounds. Eur. Respir. J. 1992; 5: 685-692.

87. Olia P.M., Sestini P., Vagliasindi M. Acoustic parameters of voluntary cough in healthy non-smoking subjects. Respirology 2000; 5: 271-275.

88. Corrigan D.L., Paton J.Y. Pilot study of objective cough monitoring in infants. Pediatr. Pulmonol. 2003; 35: 350-357.

89. Smith J.A., Earis A., Woodcock A.A., Earis J.E. Acoustic properties of spontaneous coughs in common respiratory diseases. Am. J. Respir. Crit. Care Med. 2004; 169: A200.

90. Bland J.M., Altman D.G. Comparing methods of measurement: why plotting difference against standard method is misleading. Lancet 1995; 346: 1085-1087.

91. World Health Organization. Preamble to the Constitution of the World Health Organization as adopted by the International Health Conference, New York, 19 June - 22 July 1946; signed on 22 July 1946 by the representatives of 61 States. (Official records of the World Health Organization, no. 2, p. 100) and entered into force on 7 April 1948.

92. French C.L., Irwin R.S., Curley F.J., Krikorian C.J. Impact of chronic cough on quality of life. Arch. Intern. Med. 1998; 158: 1657-1661.

93. Gulsvik A., Refvem O.K. A scoring system on respiratory symptoms. Eur. Respir. J. 1988; 1: 428-432.

94. Chang A.B., Newman R.G., Carlin J.B. et al. Subjective scoring of cough in children: parent-completed vs child-completed diary cards vs an objective method. Eur. Respir. J. 1998; 11: 462-466.

95. Ellul-Micallef R. Effect of terbutaline sulphate in chronic ''allergic'' cough. Br. Med. J. (Clin. Res. Ed.) 1983; 287: 940-943.

96. Faniran A.O., Peat J.K., Woolcock A.J. Measuring persistent cough in children in epidemiological studies: development of a questionnaire and assessment of prevalence in two countries. Chest 1999; 115: 434-439.

97. Brunekreef B., Groot B., Rijcken B. et al. Reproducibility of childhood respiratory symptom questions. Eur. Respir. J. 1992; 5: 930-935.

98. Birring S.S., Brightling C.E., Symon F.A. et al. Idiopathic chronic cough: association with organ specific autoimmune disease and bronchoalveolar lymphocytosis. Thorax 2003; 58: 1066-1070.

99. Brightling C.E., Monterio W., Green R.H. et al. Induced sputum and other outcome measures in chronic obstructive pulmonary disease: safety and repeatability. Respir. Med. 2001; 95: 999-1002.

100. Birring S.S., Passant C., Patel R.B. et al. Chronic tonsillar enlargement and cough: preliminary evidence of a novel and treatable cause of chronic cough. Eur. Respir. J. 2004; 23: 199-201.

101. Brightling C.E., Ward R., Wardlaw A.J., Pavord I.D. Airway inflammation, airway responsiveness and cough before and after inhaled budesonide in patients with eosinophilic bronchitis. Eur. Respir. J. 2000; 15: 682-686.

102. Fayers P.M., Machin D. Quality of life: assessment, analysis and interpretation. 1st edn. Chichester: John Wiley & Sons, 2000.

103. Juniper E.F. Health-related quality of life. In: Barnes P.J., Grunstein M.M., Leff A.R., Woodcock A.J., eds. Asthma. Philadelphia: Lippincott-Raven; 1997. 1487-1497.

104. Baiardini I., Braido F., Fassio O. et al. A new tool to assess and monitor the burden of chronic cough on quality of life: Chronic Cough Impact Questionnaire. Allergy 2005; 60: 482-488.

105. Birring S.S., Patel R.B., Carr A.J. et al. Assessment of quality of life in acute cough with the Leicester Cough Questionnaire (LCQ). Am. J. Respir. Crit. Care Med. 2004; 169: A509.

106. Raj A.A., Pavord I.D., Birring S.S. What is the minimal important difference of the Leicester Cough Questionnaire? Thorax 2006; 21 (suppl. 2): 109.

107. Morice A.H., Menon M.S., Mulrennan S.A. et al. Opiate therapy in chronic cough. Am. J. Respir. Crit. Care Med. 2007; 175: 312-315.

108. French C.T., Fletcher K.E., Irwin R.S. A comparison of gender differences in health-related quality of life in acute and chronic coughers. Chest 2005; 127: 1991-1998.

109. French C.T., Fletcher K.E., Irwin R.S. Gender differences in health-related quality of life in patients complaining of chronic cough. Chest 2004; 125: 482-488.

110. Birring S.S., Patel R.B., Prudon B. et al. Quality of life in chronic cough. Am. J. Respir. Crit. Care Med. 2003; 167: A135.

111. Dicpinigaitis P.V., Tso R., Banauch G.I. Prevalence of depressive symptoms among patients with chronic cough. Chest 2006; 130: 1839-1843.

112. Kalpaklioglu A.F., Kara T., Kurtipek E. et al. Evaluation and impact of chronic cough: comparison of specific vs generic quality-of-life questionnaires. Ann Allergy Asthma Immunol. 2005; 94: 581-585.

113. Choudry N.B., Fuller R.W. Sensitivity of the cough reflex in patients with chronic cough. Eur. Respir. J. 1992; 5: 296-300.

114. Schroeder K., Fahey T. Systematic review of randomized controlled trials of over the counter cough medicines for acute cough in adults. Br. Med. J. 2002; 324: 1-6.

115. Karlsson J.A., Fuller R.W. Pharmacological regulation of the cough reflex - from experimental models to antitussive effects in man. Pulm. Pharmacol. Ther. 1999; 12: 215-228.

116. Moreaux B., Beerens D., Gustin P. Development of a cough induction test in pigs: effects of SR 48968 and enalapril. J. Vet. Pharmacol. Ther. 1999; 22: 387-389.

117. Kamei J., Hukuhara T., Kasuya Y. Dopaminergic control of the cough reflex as demonstrated by the effects of apomorphine. Eur. J. Pharmacol. 1987; 141: 511-513.

118. Korpas J. Differentiation of the expiration and the cough reflex. Physiol. Bohemoslov. 1972; 21: 677-680.

119. Karlsson J.A., Sant'Ambrogio G., Widdicombe J. Afferent neural pathways in cough and reflex bronchoconstriction. J. Appl. Physiol. 1988; 65: 1007-1023.

120. Forsberg K., Karlsson J.A., Theodorsson E. et al. Cough and bronchoconstriction mediated by capsaicin-sensitive sensory neurons in the guinea-pig. Pulm. Pharmacol. 1988; 1: 33-39.

121. Fox A.J., Barnes P.J., Urban L., Dray A. An in vitro study of the properties of single vagal afferents innervating guinea-pig airways. J. Physiol. (Lond.) 1993; 469: 21-35.

122. Undem B.J., Carr M.J., Kollarik M. Physiology and plasticity of putative cough fibres in the Guinea pig. Pulm. Pharmacol. Ther. 2002; 15: 193-198.

123. Fox A.J. Modulation of cough and airway sensory fibres. Pulm. Pharmacol. 1996; 9: 335-342.

124. Fox A.J., Lalloo U.G., Belvisi M.G. et al. Bradykinin-evoked sensitization of airway sensory nerves: a mechanism for ACE-inhibitor cough. Nat. Med. 1996; 2: 814-817.

125. Fox A.J., Barnes P.J., Venkatesan P., Belvisi M.G. Activation of large conductance potassium channels inhibits the afferent and efferent function of airway sensory nerves in the guinea pig. J. Clin. Invest 1997; 99: 513-519.

126. Tatar M., Pecova R., Karcolova D. Sensitivity of the cough reflex in awake guinea pigs, rats and rabbits. Bratisl. Lek. Listy 1997; 98: 539-543.

127. Lalloo U.G., Fox A.J., Belvisi M.G. et al. Capsazepine inhibits cough induced by capsaicin and citric acid but not by hypertonic saline in guinea pigs. J. Appl. Physiol. 1995; 79: 1082-1087.

128. Hay D.W., Giardina G.A., Griswold D.E. et al. Nonpeptide tachykinin receptor antagonists. III. SB 235375, a low central nervous system-penetrant, potent and selective neurokinin-3 receptor antagonist, inhibits citric acid-induced cough and airways hyper-reactivity in guinea pigs. J. Pharmacol. Exp. Ther. 2002; 300: 314-323.

129. Emonds-Alt X., Advenier C., Cognon C. et al. Biochemical and pharmacological activities of SR 144190, a new potent non-peptide tachykinin NK2 receptor antagonist. Neuropeptides 1997; 31: 449-458.

130. Belvisi M.G., Venkatesan P., Barnes P.J., Fox A.J. A comparison of the chemosensitivity of the isolated guinea pig and human vagus nerves. Am. J. Respir. Crit. Care Med. 1998; 157: A487.

131. Canning B.J., Mazzone S.B., Meeker S.N. et al. Identification of the tracheal and laryngeal afferent neurones mediating cough in anaesthetized guinea-pigs. J. Physiol. (Lond.) 2004; 557: 543-558.

132. Mazzone S.B., Mori N., Canning B.J. Synergistic interactions between airway afferent nerve subtypes regulating the cough reflex in guinea-pigs. J. Physiol. (Lond.) 2005; 569: 559-573.

133. Bolser D.C., Hey J.A., Chapman R.W. Influence of central antitussive drugs on the cough motor pattern. J. Appl. Physiol. 1999; 86: 1017-1024.

134. Bolser D.C., Mcleod R.L., Tulshian D.B., Hey J.A. Antitussive action of nociceptin in the cat. Eur. J. Pharmacol 2001; 430: 107-111.

135. Bolser D.C., Aziz S.M., DeGennaro F.C. et al. Antitussive effects of GABAB agonists in the cat and guinea-pig. Br. J. Pharmacol. 1993; 110: 491-495.

136. Tatar M., Pecova R. Laryngeal and tracheobronchial cough in anaesthetized cats and guinea-pigs. Stud. Pneumol. Phtiseol. 1994; 54: 143-145.

137. Plevkova J., Kollarik M., Brozmanova M. et al. Modulation of experimentally induced cough by stimulation of nasal mucosa in cats and guinea pigs. Respir. Physiol. Neurobiol. 2004; 142: 225-235.

138. Tatar M., Karcolova D., Pecova R. et al. Experimental modulation of the cough reflex. Eur. Respir. Rev. 2002; 12: 264-269.

139. Widdicombe J. Sensory mechanisms. Pulm. Pharmacol. 1996; 9: 383-387.

140. Moreaux B., Nemmar A., Beerens D., Gustin P. Inhibiting effect of ammonia on citric acid-induced cough in pigs: a possible involvement of substance P. Pharmacol. and Toxicol. 2000; 87: 279-285.

141. Xiang A., Uchida Y., Nomura A. et al. Effects of airway inflammation on cough response in the guinea pig. J. Appl. Physiol. 1998; 85: 1847-1854.

142. Liu Q., Fujimura M., Tachibana H. et al. Characterization of increased cough sensitivity after antigen challenge in guinea pigs. Clin. Exp. Allergy 2001; 31: 474-484.

143. House A., Celly C., Skeans S. et al. Cough reflex in allergic dogs. Eur. J. Pharmacol. 2004; 492: 251-258.

144. Hirata R., Nabe T., Kohno S. Augmentation of spontaneous cough by enalapril through up-regulation of bradykinin B1 receptors in guinea pigs. Eur. J. Pharmacol 2003; 474: 255-260.

145. Ito K., Ito K., Sawada Y. et al. Toxicodynamic analysis of cough and inflammatory reactions by angiotensin-converting enzyme inhibitors in guinea pig. J. Pharmacol. Exp. Ther. 1995; 275: 920-925.

146. Bergren D.R. Chronic tobacco smoke exposure increases cough to capsaicin in awake guinea pigs. Respir. Physiol. 2001; 126: 127-140.

147. Joad J.P., Munch P.A., Bric J.M. et al. Passive smoke effects on cough and airways in young guinea pigs: role of brainstem substance P. Am. J. Respir. Crit. Care Med. 2004; 169: 499-504.

148. Karlsson J.A., Zackrisson C., Lundberg J.M. Hyperresponsiveness to tussive stimuli in cigarette smoke-exposed guinea-pigs: a role for capsaicin-sensitive, calcitonin gene-related peptide-containing nerves. Acta. Physiol. Scand. 1991; 141: 445-454.

149. Myers A.C., Kajekar R., Undem B.J. Allergic inflammation-induced neuropeptide production in rapidly adapting afferent nerves in guinea pig airways. Am. J. Physiol. Lung Cell Mol. Physiol. 2002; 282: L775-L781.

150. Hunter D.D., Myers A.C., Undem B.J. Nerve growth factor-induced phenotypic switch in guinea pig airway sensory neurons. Am. J. Respir. Crit. Care Med. 2000; 161: 1985-1990.

151. Riccio M.M., Myers A.C., Undem B.J. Immunomodulation of afferent neurons in guinea-pig isolated airway. J. Physiol. (Lond.) 1996; 491: 499-509.

152. Advenier C. Tachykinin NK2 receptors further characterized in the lung with nonpeptide receptor antagonists. Can. J. Physiol. Pharmacol. 1995; 73: 878-884.

153. Dicpinigaitis P.V., Dobkin J.B., Reichel J. Antitussive effect of the leukotriene receptor antagonist zafirlukast in subjects with cough-variant asthma. J. Asthma 2002; 39: 291-297.

154. O'Connell F., Thomas V.E., Pride N.B., Fuller R.W. Capsaicin cough sensitivity decreases with successful treatment of chronic cough. Am. J. Respir. Crit. Care Med. 1994; 150: 374-380.

155. Groneberg D.A., Niimi A., Dinh Q.T. et al. Increased expression of transient receptor potential vanilloid-1 in airway nerves of chronic cough. Am. J. Respir. Crit. Care Med. 2004; 170: 1276-1280.

156. Mitchell J.E., Campbell A.P., New N.E. et al. Expression and characterization of the intracellular vanilloid receptor (TRPV1) in bronchi from patients with chronic cough. Exp Lung Res 2005; 31: 295-306.

157. Undem B.J., Chuaychoo B., Lee M.G. et al. Subtypes of vagal afferent Cfibres in guinea-pig lungs. J. Physiol. (Lond.) 2004; 556: 905-917.

158. Dicpinigaitis P.V., Dobkin J.B. Effect of zafirlukast on cough reflex sensitivity in asthmatics. J. Asthma 1999; 36: 265-270.

159. Brightling C.E., Bradding P., Symon F.A. et al. Mast cell infiltration of airway smooth muscle in asthma. N. Engl. J. Med. 2002; 346: 1699-1705.

160. Manap R.A., Wright C.E., Gregory A. et al. The antitussive effect of dextromethorphan in relation to CYP2D6 activity. Br. J. Clin. Pharmacol. 1999; 48: 382-387.

161. Coulter D.M., Edwards I.R. Cough associated with captopril and enalapril. Br. Med. J. (Clin. Res. Ed.) 1987; 294: 1521-1523.

162. Mulrennan S., Wright C., Thompson R. et al. Effect of salbutamol on smoking related cough. Pulm. Pharmacol. Ther. 2004; 17: 127-131.

163. Dicpinigaitis P.V. Cough reflex sensitivity in cigarette smokers. Chest 2003; 123: 685-688.

164. Tomlinson J.E., McMahon A.D., Chaudhuri R. et al. Efficacy of low and high dose inhaled corticosteroid in smokers versus non-smokers with mild asthma. Thorax 2005; 60: 282-287.

165. Eccles R., Morris S., Jawad M. Lack of effect of codeine in the treatment of cough associated with acute upper respiratory tract infection. J. Clin. Pharmacol. Ther. 1992; 17: 175-180.

166. Eccles R. The powerful placebo in cough studies? Pulm. Pharmacol. Ther. 2002; 15: 303-308.

167. Pavesi L., Subburaj S., Porter-Shaw K. Application and validation of a computerized cough acquisition system for objective monitoring of acute cough: a meta-analysis. Chest 2002; 120: 1121-1128.

168. Morice A.H., Kastelik J.A. Cough. 1: Chronic cough in adults. Thorax 2003; 58: 901-907.

169. Kiljander T.O., Salomaa E.R., Hietanen E.K. et al. Gastroesophageal reflux and bronchial responsiveness: correlation and the effect of fundoplication. Respiration 2002; 69: 434-439.

170. Harding S.M. Recent clinical investigations examining the association of asthma and gastroesophageal reflux. Am. J. Med. 2003; 115 (suppl. 3A): 39S-44S.